Sections

Weather Forecast

Close

Pharma Bro

August 4, 2017
Martin Shkreli exits federal court following the third day of jury deliberations in his fraud trial, in New York, Aug. 2, 2017. Shkreli, a divisive pharmaceutical executive who sharply raised the price of a lifesaving drug, Daraprim, overnight and got into high-profile tussles on social media, is accused of securities and wire fraud. (Louis Lanzano/The New York Times)
'Pharma Bro' Martin Shkreli found guilty of securities fraud, faces up to 20 years in prison
August 4, 2017 - 2:21pm
randomness